Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 13 studies | 39% ± 18% | |
glutamatergic neuron | 12 studies | 72% ± 21% | |
GABAergic neuron | 11 studies | 57% ± 26% | |
retinal ganglion cell | 7 studies | 43% ± 18% | |
neuron | 6 studies | 39% ± 17% | |
interneuron | 6 studies | 64% ± 26% | |
endothelial cell | 5 studies | 37% ± 22% | |
amacrine cell | 5 studies | 33% ± 12% | |
retinal cone cell | 5 studies | 33% ± 17% | |
granule cell | 4 studies | 63% ± 24% | |
GABAergic interneuron | 3 studies | 69% ± 6% | |
retinal bipolar neuron | 3 studies | 23% ± 4% | |
GABAergic amacrine cell | 3 studies | 44% ± 13% | |
OFF-bipolar cell | 3 studies | 28% ± 13% | |
ON-bipolar cell | 3 studies | 26% ± 11% | |
glycinergic amacrine cell | 3 studies | 38% ± 10% | |
rod bipolar cell | 3 studies | 24% ± 10% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 46% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 10347.52 | 2577 / 2642 | 93% | 6.32 | 656 / 705 |
kidney | 100% | 1673.67 | 89 / 89 | 13% | 0.44 | 115 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.40 | 1 / 1 |
adrenal gland | 16% | 136.95 | 41 / 258 | 66% | 3.54 | 152 / 230 |
uterus | 22% | 114.70 | 38 / 170 | 18% | 0.50 | 82 / 459 |
breast | 14% | 110.10 | 62 / 459 | 8% | 0.20 | 88 / 1118 |
esophagus | 1% | 2.43 | 8 / 1445 | 14% | 0.58 | 25 / 183 |
stomach | 5% | 24.11 | 17 / 359 | 7% | 0.15 | 20 / 286 |
lung | 0% | 0 | 0 / 578 | 10% | 0.40 | 121 / 1155 |
ovary | 2% | 8.63 | 3 / 180 | 7% | 0.13 | 28 / 430 |
pancreas | 0% | 0 | 0 / 328 | 7% | 0.15 | 13 / 178 |
bladder | 0% | 0 | 0 / 21 | 7% | 0.16 | 33 / 504 |
skin | 1% | 6.34 | 20 / 1809 | 5% | 0.11 | 24 / 472 |
prostate | 2% | 9.94 | 4 / 245 | 4% | 0.07 | 22 / 502 |
intestine | 0% | 1.70 | 3 / 966 | 4% | 0.09 | 19 / 527 |
adipose | 4% | 18.49 | 43 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.15 | 1 / 29 |
blood vessel | 3% | 12.30 | 34 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
liver | 0% | 0 | 0 / 226 | 1% | 0.02 | 5 / 406 |
thymus | 0% | 0 | 0 / 653 | 1% | 0.02 | 7 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0086002 | Biological process | cardiac muscle cell action potential involved in contraction |
GO_0042552 | Biological process | myelination |
GO_0021675 | Biological process | nerve development |
GO_0008340 | Biological process | determination of adult lifespan |
GO_0021542 | Biological process | dentate gyrus development |
GO_0008627 | Biological process | intrinsic apoptotic signaling pathway in response to osmotic stress |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0006814 | Biological process | sodium ion transport |
GO_0019228 | Biological process | neuronal action potential |
GO_0007613 | Biological process | memory |
GO_0007399 | Biological process | nervous system development |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0030315 | Cellular component | T-tubule |
GO_0033270 | Cellular component | paranode region of axon |
GO_0033268 | Cellular component | node of Ranvier |
GO_0001518 | Cellular component | voltage-gated sodium channel complex |
GO_0030424 | Cellular component | axon |
GO_0014704 | Cellular component | intercalated disc |
GO_0005248 | Molecular function | voltage-gated sodium channel activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SCN2A |
Protein name | Sodium voltage-gated channel alpha subunit 2 Sodium channel protein Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2) |
Synonyms | SCN2A2 NAC2 HBA SCN2A1 |
Description | FUNCTION: Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient . Implicated in the regulation of hippocampal replay occurring within sharp wave ripples (SPW-R) important for memory (By similarity). . FUNCTION: Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient. . |
Accessions | ENST00000636384.2 ENST00000283256.10 [Q99250-1] ENST00000673831.1 A0A669KBL5 A0A669KAR0 ENST00000636985.2 A0A1B0GWA6 ENST00000637266.2 [Q99250-1] A0A1B0GW67 ENST00000636135.1 F6U291 Q99250 ENST00000673883.1 ENST00000424833.5 A0A0D9SGG2 ENST00000636662.2 A0A669KBM3 A0A1B0GW40 ENST00000631182.3 [Q99250-2] ENST00000636769.1 A0A1B0GTX0 ENST00000486878.2 ENST00000375437.7 [Q99250-1] ENST00000674133.1 A0A1B0GTS6 ENST00000637367.1 ENST00000636071.2 [Q99250-2] |